Amgen
The Global Pharmacovigilance Manager partners with cross-functional stakeholders to develop and execute product safety strategies across the product lifecycle, from early development through post-marketing phases. This role involves leading signal detection and management, authoring aggregate safety reports, and providing strategic safety input into clinical development and regulatory submissions. The position requires scientific leadership to support benefit-risk evaluations and ensure compliance with global pharmacovigilance regulations.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Director, Drug Safety & Pharmacovigilance - Safety Scientist
Travere Therapeutics
Senior Medical Safety Scientist
Acadia Pharmaceuticals Inc.
Senior Director, Safety & Pharmacovigilance
larimartherapeutics.com
Global Patient Safety (GPS) Pharmacovigilance Science (PVSci) Manager
Vertex
Pharmacovigilance Manager, Aggregate & Trend Reports
American Regent
Senior Director, Patient Safety & Pharmacovigilance
Latigobio